Trump et al. focus on NIH, cancer—and how peer review is done

After a year-long reign over tumult at FDA, Makary heads for the exit
Fruit-flavored e-cigs were the final blow for the commissioner

The immediate impetus for FDA Commissioner Marty Makary’s exit from the top job at FDA is arguably less significant than the legacy of dysfunction he leaves behind.

May 15, 2026

Vol.52 No.19

By Claire Marie Porter

In Brief

Providence Cancer Institute receives $3.4M NIH grant to study head-and-neck cancer treatments

The Earle A. Chiles Research Institute, a division of the Providence Cancer Institute of Oregon, received an NIH grant for its next phase of treatments for head-and-neck cancers.

May 15, 2026

Vol.52 No.19

In Brief

Northwestern Mutual to support childhood cancer survivors, siblings with $500,000 in college scholarships

Northwestern Mutual, through its Foundation, announced a class of scholars from its annual Childhood Cancer Scholarship Program for families affected by childhood cancer. The program provides scholarships to students affected by a diagnosis—either as survivors themselves or as siblings—enabling recipients to chase their dreams and transform their experience into purpose.

May 15, 2026

Vol.52 No.19

Podcast

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

The Cancer Letter’s coverage of HHS-led overhauls of foundational scientific institutions continued last week with two unrelated stories pointing to continued disarray amongst public health leadership.

May 06, 2026

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

Health and Human Services Secretary Robert F. Kennedy Jr. is moving to overhaul the U.S. Preventive Services Task Force, a highly influential panel that determines which preventive services insurers must cover and guides routine medical care for millions of Americans.

May 01, 2026

Vol.52 No.17

By Claire Marie Porter

Cancer Policy

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, voted in December to rescind its recommendation that all newborns receive a hepatitis B virus vaccine dose within 24 hours of birth.

May 01, 2026

Vol.52 No.17

By Claire Marie Porter

Trump et al. focus on NIH, cancer—and how peer review is done

YOU MAY BE INTERESTED IN

After a year-long reign over tumult at FDA, Makary heads for the exit
Fruit-flavored e-cigs were the final blow for the commissioner

Providence Cancer Institute receives $3.4M NIH grant to study head-and-neck cancer treatments

Northwestern Mutual to support childhood cancer survivors, siblings with $500,000 in college scholarships

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

Renew today!

Subscriber content

Never miss an issue!

Login

Trump et al. focus on NIH, cancer—and how peer review is done

YOU MAY BE INTERESTED IN

After a year-long reign over tumult at FDA, Makary heads for the exitFruit-flavored e-cigs were the final blow for the commissioner

Providence Cancer Institute receives $3.4M NIH grant to study head-and-neck cancer treatments

Northwestern Mutual to support childhood cancer survivors, siblings with $500,000 in college scholarships

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panelRansohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”

CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show

Never miss an issue!

Login

After a year-long reign over tumult at FDA, Makary heads for the exit
Fruit-flavored e-cigs were the final blow for the commissioner

By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”